Stock Analiz

DexCom Inc. (DXCM) stock forecast and price target

Price $83.33 · data as of November 13, 2026

12-month price target

Average target$98.58
Upside / downside+18.3%
Analysts26
ConsensusStrong buy
Low $79.00Average $98.58High $120.00

Gold marker: average target · white marker: today’s price ($83.33)

Analyst ratings

Strong buy 4Buy 22Hold 3Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$2.70+29.2%$5.2B
Next fiscal year
ends December 31, 2027
$3.13+16.1%$5.8B
Next quarter
ends December 31, 2026
$0.72+5.4%$1.4B
Quarter after
ends March 31, 2027
$0.64+13.8%$1.3B

Consensus of the analysts covering DexCom, updated daily. In the last 30 days 20 estimates were raised and 2 lowered.

Our model vs. Wall Street

Analysts see 18.3% upside over 12 months. Our discounted cash flow model with moderate assumptions puts DexCom’s intrinsic value about 41% below today’s market value, and it scores 3.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the DexCom stock price target?

The average 12-month target from 26 analysts is $98.58, 18.3% above the current price of $83.33 Targets range from $79.00 to $120.00.

Is DexCom a buy according to analysts?

The consensus rating is “Strong buy” (4 strong buy, 22 buy, 3 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is DexCom expected to earn?

Analysts expect EPS of $2.70 for the fiscal year ending December 31, 2026 and $3.13 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.